Twenty (1,5%) of 1 350 patients with malignant melanoma treated during
a 17-year period had their primary lesion in the nail bed. The thumb
(5 patients) and big toe (7) were the most commonly involved digits. M
ean delay before diagnosis was 1,4 years. Thirteen patients were black
and 7 white. Eight patients (40%) were initially misdiagnosed as havi
ng traumatic, infective or benign lesions. Four patients presented wit
h recurrent local disease after inappropriate nail excision or inadequ
ate nail biopsy, while 2 patients had regional nodal spread and 2 had
systemic metastases. Mean Breslow depth was 5,7 mm. The histogenetic s
ubtypes were acral lentiginous melanoma (12 patients) and nodular mela
noma (4 patients); 4 lesions were unclassifiable. All patients underwe
nt amputation of the involved digit and 12 required node dissection (t
herapeutic in 11, prophylactic in 1). Five patients (25%) are alive (m
ean 52 months, range 29 - 99 months); 4 are disease-free and 1 has bra
in metastases. Overall median survival was 32 months with a 26% 5-year
survival rate. Delayed diagnosis and advanced disease at presentation
contributed to the poor prognosis in nail bed melanoma.